Trials / Unknown
UnknownNCT03108560
Sublobar Resection Versus Lobectomy for cT1N0M0 Non-small-cell Lung Cancer
A Multi-center, Randomized-controlled, Open-label Clinical Trial: Sublobar Resection Versus Lobectomy for cT1N0M0 Non-small-cell Lung Cancer
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 600 (estimated)
- Sponsor
- Shanghai Zhongshan Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The incidence rate of ground-glass opacity (GGO) has been increasing these years. A great number of retrospective studies suggested that sublobar resection was better for some GGO patients. However, no prospective clinical study supports the perspective. This study is prospective, multi-center, randomized-controlled. The aim of this study is to investigate whether sublobar resection is inferior to lobectomy for cT1N0M0 non-small-cell lung cancer or not.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | sublobar resection | Patients receive sublobar resection, which includes wedge resection and segmentectomy. |
| PROCEDURE | lobectomy | patients receive lobectomy |
Timeline
- Start date
- 2017-04-18
- Primary completion
- 2023-12-31
- Completion
- 2023-12-31
- First posted
- 2017-04-11
- Last updated
- 2018-09-07
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03108560. Inclusion in this directory is not an endorsement.